These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10385308)

  • 1. Geron-Roslin alliance aims broadly at degenerative diseases.
    Fox JL
    Nat Biotechnol; 1999 Jun; 17(6):529-30. PubMed ID: 10385308
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of non-profit organizations on drug discovery: opportunities, gaps, solutions.
    Matter A; Keller TH
    Drug Discov Today; 2008 Apr; 13(7-8):347-52. PubMed ID: 18405848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AIDS vaccine duo.
    Nature; 2005 Jun; 435(7046):1159. PubMed ID: 15988492
    [No Abstract]   [Full Text] [Related]  

  • 4. An audience with... Victoria G. Hale.
    Hale VG
    Nat Rev Drug Discov; 2005 Nov; 4(11):878. PubMed ID: 16299916
    [No Abstract]   [Full Text] [Related]  

  • 5. Garry Neil. Interview by Asher Mullard.
    Neil G
    Nat Rev Drug Discov; 2012 Nov; 11(11):826. PubMed ID: 23123934
    [No Abstract]   [Full Text] [Related]  

  • 6. Cause-related marketing: the uneasy alliance between altruism and corporate greed.
    Lingen MW
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Apr; 105(4):407-9. PubMed ID: 18329575
    [No Abstract]   [Full Text] [Related]  

  • 7. ALLICENSE 2007--A Recombinant Capital Conference. Enhancing productivity through alliances.
    Pestonjamasp V
    IDrugs; 2007 Jun; 10(6):377-82. PubMed ID: 17641999
    [No Abstract]   [Full Text] [Related]  

  • 8. Funding alert: wake up and support WORLD.
    James JS
    AIDS Treat News; 2003 May; (391):6-7. PubMed ID: 12866498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Links between non-profit foundations and companies pose potential conflicts of interest.
    Limb M
    BMJ; 2011 Apr; 342():d2490. PubMed ID: 21498467
    [No Abstract]   [Full Text] [Related]  

  • 10. World's first nonprofit drug company launched.
    Cassels A
    CMAJ; 2003 Sep; 169(6):590. PubMed ID: 12975232
    [No Abstract]   [Full Text] [Related]  

  • 11. When times get tough.
    Jong S
    Nat Biotechnol; 2009 Mar; 27(3):226-8. PubMed ID: 19274868
    [No Abstract]   [Full Text] [Related]  

  • 12. Genentech grapples with direct offer.
    Huggett B
    Nat Biotechnol; 2009 Mar; 27(3):212. PubMed ID: 19270652
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyseq-Variagenics merger signals end of the line.
    Hodgson J
    Nat Biotechnol; 2003 Jan; 21(1):5. PubMed ID: 12511895
    [No Abstract]   [Full Text] [Related]  

  • 14. Vaccine venture boosts health hopes.
    Butler D
    Nature; 2009 Sep; 461(7262):323. PubMed ID: 19759588
    [No Abstract]   [Full Text] [Related]  

  • 15. Does biotech M&A benefit investors?
    Jacobs T
    Nat Biotechnol; 2004 Sep; 22(9):1085. PubMed ID: 15340472
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibiotics at the crossroads.
    Nathan C
    Nature; 2004 Oct; 431(7011):899-902. PubMed ID: 15496893
    [No Abstract]   [Full Text] [Related]  

  • 17. Not-for-profit advocate calls for managerial rigor.
    Berman HJ
    Manag Care; 2004 Feb; 13(2):24, 26-9. PubMed ID: 15004927
    [No Abstract]   [Full Text] [Related]  

  • 18. A good vaccine is hard to find: nonprofit biotechs tackle tuberculosis.
    Wolfson W
    Chem Biol; 2008 Oct; 15(10):997-8. PubMed ID: 18940659
    [No Abstract]   [Full Text] [Related]  

  • 19. Wellcome and Zeneca form genetic alliance.
    Dickson D
    Nature; 1995 Jul; 376(6535):9. PubMed ID: 7596442
    [No Abstract]   [Full Text] [Related]  

  • 20. Initial lessons from public-private partnerships in drug and vaccine development.
    Wheeler C; Berkley S
    Bull World Health Organ; 2001; 79(8):728-34. PubMed ID: 11545329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.